didn't lose weight on semaglutide DEXA Scan Woman Loses 82lbs on Semaglutide

GLP-1 medications improve insulin sensitivity and reduce visceral fat, hence, directly addressing the metabolic drivers of PCOS/PMOS, not just appetite

This makes it a safer and more sustainable long-term option for hormone optimization

(1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

For alcohol use disorder, naltrexone is an established, FDA-approved option

L-carnitine is an amino acid that your body needs to convert fat into energy

The SwiftyRx/CenterWell employer model, if it scales, routes generic drug procurement for insured Americans around PBM markup